101 related articles for article (PubMed ID: 2664326)
1. [Examination strategies in the diagnosis of drug-induced retinal damage].
Niemeyer G; Früh B
Klin Monbl Augenheilkd; 1989 May; 194(5):355-8. PubMed ID: 2664326
[TBL] [Abstract][Full Text] [Related]
2. The blood-retinal barrier in chloroquine retinopathy.
Raines MF; Bhargava SK; Rosen ES
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
4. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
5. Detection of color vision defects in chloroquine retinopathy.
Vu BL; Easterbrook M; Hovis JK
Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
[TBL] [Abstract][Full Text] [Related]
6. Blue-yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy.
Razeghinejad MR; Torkaman F; Amini H
Med Hypotheses; 2005; 65(3):629-30. PubMed ID: 15949899
[No Abstract] [Full Text] [Related]
7. The sensitivity of Amsler grid testing in early chloroquine retinopathy.
Easterbrook M
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():204-7. PubMed ID: 3857780
[TBL] [Abstract][Full Text] [Related]
8. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
9. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.
Marmor MF
Arthritis Rheum; 2003 Jun; 48(6):1764. PubMed ID: 12794848
[No Abstract] [Full Text] [Related]
10. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
Kobak S; Deveci H
Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
Ruiz RS; Saatci OA
Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
[TBL] [Abstract][Full Text] [Related]
12. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity.
Anderson C; Pahk P; Blaha GR; Spindel GP; Alster Y; Rafaeli O; Marx JL
Retina; 2009 Sep; 29(8):1188-92. PubMed ID: 19491724
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy].
Meyniel G; Doly M; Millerin M; Braquet P
C R Acad Sci III; 1992; 314(2):61-5. PubMed ID: 1559183
[TBL] [Abstract][Full Text] [Related]
14. [Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy (author's transl)].
Jaeger W
Klin Monbl Augenheilkd; 1977 Mar; 170(3):453-60. PubMed ID: 17031
[TBL] [Abstract][Full Text] [Related]
15. Ocular safety of hydroxychloroquine.
Bernstein HN
Ann Ophthalmol; 1991 Aug; 23(8):292-6. PubMed ID: 1952638
[TBL] [Abstract][Full Text] [Related]
16. Dose relationships in patients with early chloroquine retinopathy.
Easterbrook M
J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine retinopathy in the rhesus monkey.
Rosenthal AR; Kolb H; Bergsma D; Huxsoll D; Hopkins JL
Invest Ophthalmol Vis Sci; 1978 Dec; 17(12):1158-75. PubMed ID: 102610
[TBL] [Abstract][Full Text] [Related]
18. [Retinal pigment epithelium--the point about safety of antimalarial agents].
Vanheesbeke A
Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227
[TBL] [Abstract][Full Text] [Related]
19. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
Hart WM; Burde RM; Johnston GP; Drews RC
Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
[TBL] [Abstract][Full Text] [Related]
20. Current concepts in monitoring patients on antimalarials.
Easterbrook M
Aust N Z J Ophthalmol; 1998 May; 26(2):101-3. PubMed ID: 9630287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
